| Financial Year |
March 31 2023 |
| Monetary Funds |
210,814,724.96 |
| Held-for-trading Financial Assets |
129,276,806.94 |
| Notes Receivable |
28,983,260.02 |
| Accounts Receivable |
392,824,250.56 |
| Advances to Suppliers |
80,529,497.82 |
| Other Receivables |
1,842,423.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
286,518,723.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
243,756.91 |
| Total Current Assets |
1,195,455,488.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
273,909,197.29 |
| Under-construction Projects |
158,230.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,069,079.73 |
| R&D expenses |
-- |
| Goodwill |
24,747,206.85 |
| Long-Term Deferred and Prepaid Expenses |
1,400,889.06 |
| Deferred Income Tax Assets |
5,605,798.79 |
| Other Non-Current Assets |
3,822,853.26 |
| Sub-Total of Non-Current Assets |
385,213,869.78 |
| Total Assets |
1,580,669,358.55 |
| Short-Term Loans |
641,438,195.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,000,000.00 |
| Accounts Payable |
87,838,946.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,655,141.29 |
| Taxes Payable |
9,824,130.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,340,957.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,468,198.67 |
| Other Current Liabilities |
3,325,132.92 |
| Sub-Total of Current Liabilities |
785,622,971.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,779,907.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,577,174.42 |
| Total Liabilities |
811,200,146.06 |
| Paid-In Capital(Or Share Stock) |
217,730,187.00 |
| Capital Surplus |
340,159,938.68 |
| Surplus Reserve |
51,856,052.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
113,831,090.45 |
| Minority Stockholder's Interest |
45,891,943.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
723,577,268.72 |
| Owner's Equity（Stockholder's Equity） |
769,469,212.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,580,669,358.55 |
